Risk-adapted Biopsy Decision Based on Prostate Magnetic Resonance Imaging and Prostate-specific Antigen Density for Enhanced Biopsy Avoidance in First Prostate Cancer Diagnostic Evaluation

Overview

Journal BJU Int

Specialty Urology

Date 2020 Oct 22

PMID 33089586

Citations 42

Authors

Ivo G Schoots

Anwar R Padhani

Affiliations

Soon will be listed here.

Citing Articles

Optimal PSA density threshold for prostate biopsy in benign prostatic obstruction patients with elevated PSA levels but negative MRI findings.

Peng Y, Wei C, Li Y, Zhao F, Liu Y, Jiang T BMC Urol. 2025; 25(1):42.

PMID: 40033313 PMC: 11874838. DOI: 10.1186/s12894-025-01719-5.

Patients with multiple mpMRI region of interests: should we omit targeted biopsies of secondary lesions?.

Qin F, Yuan C, Ma J, Li H, Zhang J, Liu Y Abdom Radiol (NY). 2025; .

PMID: 39992404 DOI: 10.1007/s00261-025-04854-7.

Integrating radiological and clinical data for clinically significant prostate cancer detection with machine learning techniques.

Esteban L, Borque-Fernando A, Escorihuela M, Esteban-Escano J, Abascal J, Servian P Sci Rep. 2025; 15(1):4261.

PMID: 39905119 PMC: 11794621. DOI: 10.1038/s41598-025-88297-6.

Can lesion volume and prostate-specific antigen density play a role in detecting clinically significant prostate cancer in Prostate Imaging Reporting and Data System-3 lesions on multiparametric magnetic resonance imaging?.

Agrawal S, Prasad V, Menon A, Pooleri G Indian J Urol. 2025; 41(1):35-39.

PMID: 39886626 PMC: 11778701. DOI: 10.4103/iju.iju_112_24.

Screening for prostate cancer: evidence, ongoing trials, policies and knowledge gaps.

Bratt O, Auvinen A, Arnsrud Godtman R, Hellstrom M, Hugosson J, Lilja H BMJ Oncol. 2025; 2(1):e000039.

PMID: 39886507 PMC: 11203092. DOI: 10.1136/bmjonc-2023-000039.

References

van der Leest M, Cornel E, Israel B, Hendriks R, Padhani A, Hoogenboom M . Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naïve Men with Elevated Prostate-specific Antigen: A Large.... Eur Urol. 2018; 75(4):570-578. DOI: 10.1016/j.eururo.2018.11.023. View

Schoots I, Padhani A . Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?. World J Urol. 2019; 38(3):531-545. PMC: 7064475. DOI: 10.1007/s00345-019-02899-0. View

Hansen N, Barrett T, Kesch C, Pepdjonovic L, Bonekamp D, OSullivan R . Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naïve men with suspicion of prostate cancer. BJU Int. 2017; 122(1):40-49. DOI: 10.1111/bju.14049. View

Padhani A, Barentsz J, Villeirs G, Rosenkrantz A, Margolis D, Turkbey B . PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway. Radiology. 2019; 292(2):464-474. PMC: 6677282. DOI: 10.1148/radiol.2019182946. View

Drost F, Osses D, Nieboer D, Steyerberg E, Bangma C, Roobol M . Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev. 2019; 4:CD012663. PMC: 6483565. DOI: 10.1002/14651858.CD012663.pub2. View

Stevens E, Truong M, Bullen J, Ward R, Purysko A, Klein E . Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer. Urol Oncol. 2020; 38(11):846.e9-846.e16. DOI: 10.1016/j.urolonc.2020.05.024. View

Thompson I, Pauler D, Goodman P, Tangen C, Lucia M, Parnes H . Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N Engl J Med. 2004; 350(22):2239-46. DOI: 10.1056/NEJMoa031918. View

Schoots I, Roobol M . Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions. World J Urol. 2019; 38(3):517-529. PMC: 7064454. DOI: 10.1007/s00345-019-02707-9. View

Boesen L, Norgaard N, Logager V, Balslev I, Bisbjerg R, Thestrup K . Prebiopsy Biparametric Magnetic Resonance Imaging Combined with Prostate-specific Antigen Density in Detecting and Ruling out Gleason 7-10 Prostate Cancer in Biopsy-naïve Men. Eur Urol Oncol. 2019; 2(3):311-319. DOI: 10.1016/j.euo.2018.09.001. View

10.

Knaapila J, Jambor I, Montoya Perez I, Ettala O, Taimen P, Verho J . Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study. Eur Urol Oncol. 2019; 3(5):648-656. DOI: 10.1016/j.euo.2019.08.008. View

11.

Falagario U, Martini A, Wajswol E, Treacy P, Ratnani P, Jambor I . Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators. Eur Urol Oncol. 2019; 3(5):700-704. DOI: 10.1016/j.euo.2019.08.015. View